AIP
IMUX icon

Ameritas Investment Partners’s Immunic IMUX Stock Holding History

Ameritas Investment Partners’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-122
Closed -$14K – 3147
2022
Q1 		$14K Hold
122
– – ﹤0.01% 2686
2021
Q4 		$12K Hold
122
– – ﹤0.01% 2842
2021
Q3 		$11K Hold
122
– – ﹤0.01% 2914
2021
Q2 		$15K Buy
122
+92
+307% +$12.7K ﹤0.01% 2851
2021
Q1 		$5K Hold
30
– – ﹤0.01% 3002
2020
Q4 		$5K Hold
30
– – ﹤0.01% 2972
2020
Q3 		$6K Hold
30
– – ﹤0.01% 2921
2020
Q2 		$4K Buy
+30
New +$3.05K ﹤0.01% 2991
2019
Q2 		– Sell
-6
Closed -$1K – 3082
2019
Q1 		$1K Hold
6
– – ﹤0.01% 2965
2018
Q4 		$0 Hold
6
– – ﹤0.01% 2996
2018
Q3 		$1K Hold
6
– – ﹤0.01% 3011
2018
Q2 		$18K Buy
+6
New +$13.9K ﹤0.01% 2563
2017
Q2 		– Sell
-3
Closed -$5K – 3018
2017
Q1 		$5K Buy
+3
New +$5.49K ﹤0.01% 2838

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Ameritas Investment Partners's IMUX Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Immunic (IMUX) in Q2 2022, closing a stake of 122 shares — an estimated $14K sold.

Ameritas Investment Partners first reported a position in IMUX in Q1 2017 and held it in 13 quarters. The position peaked at $18K in Q2 2018. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • Ameritas Investment Partners reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 122 Immunic shares in Q2 2022, an estimated $14K.
  • Ameritas Investment Partners first reported a position in Immunic in Q1 2017 and held it in 13 quarters.
  • Ameritas Investment Partners's Immunic position peaked at $18K in Q2 2018.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.